Doximity and Wolters Kluwer partner to add UpToDate to Ask tool

Tue, 20 Oct 2026 09:30:35 -0400

Doximity (NYSE: DOCS) and Wolters Kluwer Health announced a partnership to integrate UpToDate's clinical content directly into Doximity's AI clinical decision support tool, Ask, according to a joint press release.

In the coming weeks, clinicians at health systems using both Doximity and UpToDate will be able to view responses drawn from UpToDate's library of 13,000 topics and best practice guides alongside Doximity Ask's AI-generated answers. UpToDate's content is developed by a network of 7,600 expert clinicians, editors, and peer reviewers.

"Doctors know the value of a second opinion," said Jeff Tangney, CEO of Doximity. "With UpToDate available inside Doximity Ask, they can

Doximity and Wolters Kluwer partner to add UpToDate to Ask tool

Tue, 20 Oct 2026 09:30:35 -0400

"Doctors know the value of a second opinion," said Jeff Tangney, CEO of Doximity. "With UpToDate available inside Doximity Ask, they can

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Tue, 20 Oct 2026 09:30:00 -0400

Physicians can see Doximity Ask's AI-generated answer in addition to expert-written content from UpToDate

SAN FRANCISCO & WALTHAM, Mass.--(BUSINESS WIRE)-- Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, and Wolters Kluwer Health, today announced that UpToDate’s trusted, evidence-based, clinical content will be accessible directly within Doximity’s fast-growing AI clinical decision support tool, Ask.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020851804/en/

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Tue, 20 Oct 2026 09:30:00 -0400

Physicians can see Doximity Ask's AI-generated answer in addition to expert-written content from UpToDate

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020851804/en/

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Tue, 20 Oct 2026 09:30:00 -0400

Physicians can see Doximity Ask's AI-generated answer in addition to expert-written content from UpToDate

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020851804/en/

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Tue, 20 Oct 2026 09:30:00 -0400

Physicians can see Doximity Ask's AI-generated answer in addition to expert-written content from UpToDate

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020851804/en/

Form 4 Doximity, Inc. For: Oct 14 Filed by: Sitaram Siddharth

Fri, 16 Oct 2026 18:46:00 -0400

si-local-file:///var/storage/secattach/20261016/27198928.html

Raymond James on Doximity Inc (DOCS) Court Filing: 'we see this as a potential positive'

Fri, 16 Oct 2026 09:49:45 -0400

Raymond James analyst Brian Peterson reiterated an Outperform rating and $38.00 price target on Doximity Inc (NYSE: DOCS).

The analyst comments "A court filing from October 15 indicates that OpenEvidence and Doximity are working towards a settlement pertaining to the legal action between the companies that commenced in June 2025. While the filing doesn’t specifically reference the terms of a settlement, it states that the parties “have reached a settlement in principle that they expect will result in the dismissal of the action in its entirety with prejudice and are currently in the process of finalizing their written agreement.” The filing

Raymond James on Doximity Inc (DOCS) Court Filing: 'we see this as a potential positive'

Fri, 16 Oct 2026 09:49:45 -0400

Raymond James analyst Brian Peterson reiterated an Outperform rating and $38.00 price target on Doximity Inc (NYSE: DOCS).

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Thu, 15 Oct 2026 16:05:00 -0400

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2026 after market close on November 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.

To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call.

About Doximity

Founded in 2010, Doximity is the

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Thu, 15 Oct 2026 16:05:00 -0400

About Doximity

Founded in 2010, Doximity is the

Form 144 Doximity, Inc. Filed by: Sitaram Siddharth

Wed, 14 Oct 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20261014/27187184.html

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors

Tue, 13 Oct 2026 00:01:00 -0400

Doximity helps to power U.S. News' Doctor Finder, Patient Connect appointment booking tools used by over 65 million Americans annually to find and schedule care

SAN FRANCISCO & WASHINGTON--(BUSINESS WIRE)-- Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced it has extended its 13-year partnership with U.S. News & World Report, the nation's most trusted source of independent healthcare information, rankings and guidance to help patients identify the best care for their needs.

The extension reinforces Doximity's position as a trusted data provider for U.S.

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors

Tue, 13 Oct 2026 00:01:00 -0400

Doximity helps to power U.S. News' Doctor Finder, Patient Connect appointment booking tools used by over 65 million Americans annually to find and schedule care

The extension reinforces Doximity's position as a trusted data provider for U.S.

Doximity shares climb amid broader market weakness

Thu, 08 Oct 2026 10:13:17 -0400

Doximity Inc. shares rose 3.4% during Thursday morning trading, moving against a weaker U.S. equity market. No company announcement or analyst action was identified as the catalyst for the session's gain.

The stock has recovered from an all-time low of $17.15 reached in May 2026. The advance occurred while broader U.S. equity markets declined, suggesting stock-specific buying rather than market-wide momentum.

In late September, Doximity announced its Ask AI assistant ranked first against frontier models in an independent evaluation by Fireworks as part of a new cross-industry Specialized Intelligence Index. A separate study conducted by Stanford and Harvard in July also placed

Form 4 Doximity, Inc. For: Oct 01 Filed by: Wampler Kira Scherer

Mon, 05 Oct 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20261005/27148834.html

Form 4 Doximity, Inc. For: Sep 30 Filed by: Yang Watkin Phoebe L.

Fri, 02 Oct 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20261002/27142256.html

Form 144 Doximity, Inc. Filed by: Wampler Kira Scherer

Thu, 01 Oct 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20261001/27135923.html

Form 144 Doximity, Inc. Filed by: Yang Watkin Phoebe L.

Wed, 30 Sep 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260930/27128933.html

Form 4 Doximity, Inc. For: Sep 24 Filed by: ZATZ STEVEN L

Mon, 28 Sep 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260928/27115380.html

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Mon, 28 Sep 2026 08:16:58 -0400

PHILADELPHIA, Sept. 28, 2026 (GLOBE NEWSWIRE) --

Doximity, Inc. (NYSE: DOCS):

Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Doximity, Inc. (NYSE: DOCS).

What Is This Investigation About? This investigation concerns whether certain of the Company’s officers and directors breached fiduciary duties owed to the Company. The investigation follows the filing of a federal securities class action, Michigan Laborers’ Pension Fund v. Doximity Inc., et al., Case No. 3:26-cv-10529, in the United States District Court for the Northern District of California.

If you

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Mon, 28 Sep 2026 08:16:58 -0400

PHILADELPHIA, Sept. 28, 2026 (GLOBE NEWSWIRE) --

Doximity, Inc. (NYSE: DOCS):

Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Doximity, Inc. (NYSE: DOCS).

What Is This Investigation About? This investigation concerns whether certain of the Company’s officers and directors breached fiduciary duties owed to the Company. The investigation follows the filing of a federal securities class action, Michigan Laborers’ Pension Fund v. Doximity Inc., et al., Case No. 3:26-cv-10529, in the United States District Court for the Northern District of California.

If you

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Mon, 28 Sep 2026 08:16:58 -0400

PHILADELPHIA, Sept. 28, 2026 (GLOBE NEWSWIRE) --

Doximity, Inc. (NYSE: DOCS):

Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Doximity, Inc. (NYSE: DOCS).

What Is This Investigation About? This investigation concerns whether certain of the Company’s officers and directors breached fiduciary duties owed to the Company. The investigation follows the filing of a federal securities class action, Michigan Laborers’ Pension Fund v. Doximity Inc., et al., Case No. 3:26-cv-10529, in the United States District Court for the Northern District of California.

If you

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Mon, 28 Sep 2026 08:16:58 -0400

PHILADELPHIA, Sept. 28, 2026 (GLOBE NEWSWIRE) --

Doximity, Inc. (NYSE: DOCS):

Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Doximity, Inc. (NYSE: DOCS).

What Is This Investigation About? This investigation concerns whether certain of the Company’s officers and directors breached fiduciary duties owed to the Company. The investigation follows the filing of a federal securities class action, Michigan Laborers’ Pension Fund v. Doximity Inc., et al., Case No. 3:26-cv-10529, in the United States District Court for the Northern District of California.

If you

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Mon, 28 Sep 2026 08:16:58 -0400

PHILADELPHIA, Sept. 28, 2026 (GLOBE NEWSWIRE) --

Doximity, Inc. (NYSE: DOCS):

Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Doximity, Inc. (NYSE: DOCS).

What Is This Investigation About? This investigation concerns whether certain of the Company’s officers and directors breached fiduciary duties owed to the Company. The investigation follows the filing of a federal securities class action, Michigan Laborers’ Pension Fund v. Doximity Inc., et al., Case No. 3:26-cv-10529, in the United States District Court for the Northern District of California.

If you

StreetInsider.com News Articles

Doximity and Wolters Kluwer partner to add UpToDate to Ask tool

Doximity and Wolters Kluwer partner to add UpToDate to Ask tool

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Form 4 Doximity, Inc. For: Oct 14 Filed by: Sitaram Siddharth

Raymond James on Doximity Inc (DOCS) Court Filing: 'we see this as a potential positive'

Raymond James on Doximity Inc (DOCS) Court Filing: 'we see this as a potential positive'

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Form 144 Doximity, Inc. Filed by: Sitaram Siddharth

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors

Doximity shares climb amid broader market weakness

Form 4 Doximity, Inc. For: Oct 01 Filed by: Wampler Kira Scherer

Form 4 Doximity, Inc. For: Sep 30 Filed by: Yang Watkin Phoebe L.

Form 144 Doximity, Inc. Filed by: Wampler Kira Scherer

Form 144 Doximity, Inc. Filed by: Yang Watkin Phoebe L.

Form 4 Doximity, Inc. For: Sep 24 Filed by: ZATZ STEVEN L

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law